USPTO Examiner FREDRICKSON COURTNEY B - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18818944Medicament Delivery DeviceAugust 2024March 2025Allow711YesNo
18787166MEDICAL TREATMENT SYSTEM AND METHODS USING A PLURALITY OF FLUID LINESJuly 2024November 2024Allow410NoNo
18770644BREAST PUMP DEVICE, BREAST PUMP SYSTEM, AND METHOD FOR OPERATING THE SAMEJuly 2024June 2025Allow1121YesNo
18620501Attachment Mechanism, Module and Assembly HerewithMarch 2024October 2024Allow711NoNo
18598763IMPLANT PLACEMENT AND REMOVAL SYSTEMSMarch 2024March 2025Abandon1201NoNo
18593828METHODS AND DEVICES FOR HANDLING A FLUID AND DELIVERING THE FLUID TO THE EYEMarch 2024September 2024Allow700YesNo
18434351TRACK-INDEXED SYRINGEFebruary 2024April 2025Allow1520NoNo
18422107ESOPHAGEAL INTUBATION ASSEMBLIES FOR CARDIAC STIMULATION AND ACCESS TO GASTRIC CONTENTSJanuary 2024March 2025Allow1400NoNo
18414031SELECTIVE MODULATION OF RENAL NERVESJanuary 2024June 2025Abandon1720YesNo
18402873Huber Safety NeedleJanuary 2024February 2025Abandon1300NoNo
18499818PROGRESSIVE FLEXIBILITY CATHETER SUPPORT FRAMENovember 2023October 2024Allow1110NoNo
18498313APPARATUS, METHODS, AND SYSTEMS FOR POSITIONING AND RETAINING A NASALLY INTRODUCED MEDICAL TUBE TO A PATIENTOctober 2023March 2025Allow1620YesNo
18382954INFUSION CATHETERS AND RELATED SYSTEMS AND METHODSOctober 2023April 2024Allow610YesNo
18241771WEARABLE BREAST PUMP SYSTEMSeptember 2023December 2024Allow1630YesNo
18364131MEDICAL INFUSION DEVICEAugust 2023August 2024Allow1210YesNo
18362078Monitoring DeviceJuly 2023February 2025Allow1920YesNo
18353943VARIABLE FLEXIBILITY CATHETER SUPPORT FRAMEJuly 2023December 2024Abandon1710NoNo
18210454BABY BOTTLE WITH BOTTLE TOP ATTACHMENTJune 2023January 2025Allow1920YesNo
18324674FLUID MIXING DEVICE AND FLUID DELIVERY TUBE SET INCLUDING SAMEMay 2023April 2024Allow1100YesNo
18306477MANIFOLD FOR INFUSION SYSTEMApril 2023January 2024Abandon920NoNo
18306632CATHETER SHAFT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSApril 2023April 2024Allow1200YesNo
18148864WEARABLE BREAST PUMP SYSTEMDecember 2022September 2023Allow810YesNo
17980364SYSTEM AND METHOD FOR DELIVERY OF GAS TO A TISSUENovember 2022July 2023Allow800YesNo
17979589TRACK-INDEXED SYRINGENovember 2022October 2023Allow1110NoNo
17967229INFUSION PUMP ASSEMBLYOctober 2022December 2024Allow2630NoNo
17937289SELECTIVE MODULATION OF RENAL NERVESSeptember 2022September 2023Allow1210YesNo
17954195SELF-FLUSHING CONNECTORSeptember 2022June 2023Allow800YesNo
17939329BREAST PUMP DEVICESeptember 2022April 2024Allow1921NoNo
17902075Huber Safety NeedleSeptember 2022October 2023Allow1310YesNo
17904399FLUID MIXING SETAugust 2022March 2023Allow700YesNo
17818399Trans-Abdominal Intra-Gastric TubeAugust 2022December 2023Abandon1601NoNo
17883939ACOUSTIC DOSE METERAugust 2022November 2023Allow1630NoNo
17817120Monitoring DeviceAugust 2022May 2023Allow900YesNo
17811334MEDICAL DEVICEJuly 2022May 2023Allow1110NoNo
17859704CHEST WOUND SYSTEMJuly 2022October 2023Abandon1520NoNo
17843181FLUID INJECTOR AND PATIENT SET THEREFORJune 2022September 2024Allow2710YesNo
17837193ASSEMBLING-FACILITATED BREAST PUMPJune 2022November 2022Allow510NoNo
17749629DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USERMay 2022March 2024Allow2220YesNo
17727632CLOSED MALE LUER DEVICE FOR USE WITH NEEDLELESS ACCESS DEVICESApril 2022January 2024Allow2120YesNo
17650827SYSTEM FOR DELIVERING FLUID TO A USER TRANSCUTANEOUSLYFebruary 2022March 2024Allow2520YesNo
17581006SYSTEM FOR DISPENSING FLUIDJanuary 2022December 2024Allow3420NoNo
17580090AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAMEJanuary 2022April 2025Allow3920YesNo
17577440BREAST MILK COLLECTING METHOD BY STIMULATING MAMMARY GLAND OF BREASTFEEDER TO EJECT BREAST MILKJanuary 2022June 2025Allow4130NoNo
17577437BREAST PUMPJanuary 2022February 2025Allow3720YesNo
17577438BREAST PUMPJanuary 2022September 2024Allow3210YesNo
17576532MEDICAL INFUSION DEVICEJanuary 2022May 2023Allow1600YesNo
17573213BALLOON CATHETERJanuary 2022October 2023Allow2120NoNo
17620696SYSTEM AND METHOD FOR DELIVERY OF GAS TO A TISSUEDecember 2021October 2022Allow910NoNo
17552969SKIN TREATMENT DEVICE USING RADIOFREQUENCY AND MEDICATION AND INCLUDING TIGHTENING MEMBERDecember 2021June 2024Allow3010NoNo
17644258BREAST PUMP ASSEMBLYDecember 2021September 2022Allow910NoNo
17545970MEDICAL CHECK VALVE FOR FOOD DISTRIBUTIONDecember 2021May 2024Allow2920NoNo
17537810TREATMENT OF THE EARNovember 2021June 2025Allow4320NoNo
17537474DEVICES FOR INJECTION AND DOSINGNovember 2021January 2024Allow2620NoNo
17533476LEAK DETECTOR ON MOVABLE MEDICAL DEVICENovember 2021December 2023Allow2510NoNo
17450647BREASTMILK COLLECTION SYSTEMOctober 2021February 2024Allow2811NoNo
17491022CATHETER SHAFT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSSeptember 2021January 2023Allow1600YesNo
17481143HAND ACTUATED SUCTION AND IRRIGATION DEVICESeptember 2021June 2024Allow3300NoNo
17478881EAR, NOSE, AND THROAT IRRIGATORSeptember 2021October 2023Allow2420YesNo
17471051Medical Component Insertion Device Including a Retractable NeedleSeptember 2021November 2023Allow2621NoNo
17462334SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENTAugust 2021June 2025Abandon4611NoNo
17381831SYSTEM FOR IRRIGATING THE UPPER AERODIGESTIVE TRACT AND NEIGHBORING AREASJuly 2021November 2024Allow4011NoNo
17375001ANUS CLEANERJuly 2021October 2023Allow2710YesNo
17372673FLUID DELIVERY SYSTEM INCLUDING A HIGH CRACK PRESSURE VALVE AND METHODS FOR ITS USEJuly 2021February 2024Allow3131YesNo
17367838DOUBLE-LUMEN INFUSION CATHETER WITH INFUSION LUMEN WIDENED ALONG INTERMEDIATE SECTION THEREOFJuly 2021November 2023Abandon2910NoNo
17363893BREAST PUMP ADAPTERJune 2021December 2023Abandon2910NoNo
17328792CATHETER VENT ASSEMBLY AND RELATED SYSTEMS AND METHODSMay 2021June 2024Allow3711NoNo
17318354TREATMENT METHODMay 2021November 2022Allow1800NoNo
17228389ANTI-FREE-FLOW VALVE ASSEMBLY WITH FLOW BYPASSApril 2021August 2024Allow4110YesNo
17226377SANDWICHED BIODEGRADABLE MICRONEEDLEApril 2021September 2024Abandon4110NoNo
17283362FILTER-INTEGRATED MEDICINE TRANSFER DEVICE AND MEDICINAL LIQUID INJECTION APPARATUS INCLUDING THE SAMEApril 2021September 2024Allow4220NoNo
17210848RESUSCITATION MANAGEMENT SYSTEM FOR MANUAL RESUSCITATORSMarch 2021March 2023Allow2400NoNo
17210534RESUSCITATION MANAGEMENT SYSTEM BASED ON MAGNETIC SENSORS FOR MANUAL RESUSCITATORSMarch 2021March 2023Allow2400YesNo
17203818DIGITAL DOSAGE OF AQUEOUS MEDICINAL SOLUTIONSMarch 2021June 2024Abandon3911NoNo
17203079BREAST PUMP SYSTEMMarch 2021February 2022Allow1110YesNo
17203397BREAST PUMP SYSTEMMarch 2021August 2023Allow2930YesNo
17203150BREAST PUMP SYSTEMMarch 2021February 2023Allow2330YesNo
17203313BREAST PUMP SYSTEMMarch 2021December 2021Allow910YesNo
17203418BREAST PUMP SYSTEMMarch 2021July 2022Allow1630YesNo
17203384BREAST PUMP SYSTEMMarch 2021July 2024Abandon4030YesNo
17203292BREAST PUMP SYSTEMMarch 2021January 2023Allow2330YesNo
17203259BREAST PUMP SYSTEMMarch 2021January 2022Allow1010YesNo
17203050BREAST PUMP SYSTEMMarch 2021February 2022Allow1120YesNo
17203216BREAST PUMP SYSTEMMarch 2021February 2022Allow1110YesNo
17203109BREAST PUMP SYSTEMMarch 2021October 2021Allow710YesNo
17203179BREAST PUMP SYSTEMMarch 2021June 2023Allow2730YesNo
17203327BREAST PUMP SYSTEMMarch 2021June 2022Allow1520YesNo
17199522MEDICAL TUBE CLEARANCEMarch 2021September 2024Abandon4221NoYes
17185453MULTI-CATHETER INFUSION SYSTEM AND METHOD THEREOFFebruary 2021September 2024Allow4321NoNo
17181057BREAST PUMP SYSTEMFebruary 2021June 2024Allow4040NoNo
17178799WEARABLE MEDICAMENT DELIVERY DEVICE WITH LEAKAGE AND SKIN CONTACT SENSING AND METHOD OF USE THEREOFFebruary 2021September 2023Allow3040NoNo
17165047METHODS FOR INTRALUMINAL LOCAL DRUG DELIVERYFebruary 2021August 2023Allow3120YesNo
17264437SYSTEM AND MEDICAMENT DELIVERY DEVICE CASEJanuary 2021October 2024Allow4420YesNo
17160700VALVE ASSEMBLYJanuary 2021March 2024Allow3811NoNo
17262648BABY BOTTLE WITH BOTTLE TOP ATTACHMENTJanuary 2021December 2023Abandon3420NoNo
17262451IMPROVED INJECTION SYSTEM AND DAY SET ASSEMBLY THEREFORJanuary 2021August 2024Allow4210NoNo
17256887ROTATIONAL LOCKING TYPE SAFETY INSULIN PEN NEEDLEDecember 2020May 2024Allow4110NoNo
17256795A ROTATIONAL LOCKING TYPE SAFETY INSULIN PEN NEEDLEDecember 2020April 2024Allow4010YesNo
17123882LOW DOSE PREFILLED DRUG DELIVERY DEVICE AND METHODDecember 2020June 2023Allow3020YesNo
17121576IMPLANT PLACEMENT AND REMOVAL SYSTEMSDecember 2020May 2024Abandon4111NoNo
17118177INTEGRATED DOSE COUNTERDecember 2020May 2025Allow5331YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FREDRICKSON, COURTNEY B.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
3
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.1%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
2
(16.7%)
Not Allowed After Appeal Filing
10
(83.3%)
Filing Benefit Percentile
18.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 16.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner FREDRICKSON, COURTNEY B - Prosecution Strategy Guide

Executive Summary

Examiner FREDRICKSON, COURTNEY B works in Art Unit 3783 and has examined 333 patent applications in our dataset. With an allowance rate of 79.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner FREDRICKSON, COURTNEY B's allowance rate of 79.0% places them in the 40% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by FREDRICKSON, COURTNEY B receive 2.23 office actions before reaching final disposition. This places the examiner in the 76% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by FREDRICKSON, COURTNEY B is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +32.7% benefit to allowance rate for applications examined by FREDRICKSON, COURTNEY B. This interview benefit is in the 84% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.6% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 41.7% of cases where such amendments are filed. This entry rate is in the 57% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 55% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 55.7% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.5% of allowed cases (in the 61% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.